EUVIMEDScopri EUVIMED
LeserbriefOpen access

Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!

Mohamed G Shiha iD, Daniel Keszthelyi iD

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 420-421

DOI: 10.1111/apt.70792 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-06-12. Written by Mohamed G Shiha and 1 co-authors. Institution: Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. Cited 1 times so far (Crossref); 9 references. The full text is freely available in PubMed Central.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Authors and institutions

  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • Department of Gastroenterology, University Hospitals of Leicester, Leicester, UK.
  • Department of Gastroenterology-Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands.

ORCID profiles: Mohamed G Shiha, Daniel Keszthelyi

Cite

APA

Shiha, M. G., & Keszthelyi, D. (2026). Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!. Alimentary Pharmacology & Therapeutics, 64(3), 420-421. https://doi.org/10.1111/apt.70792

Vancouver

Shiha MG, Keszthelyi D. Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!. Alimentary Pharmacology & Therapeutics. 2026;64(3):420-421. doi:10.1111/apt.70792

BibTeX
@article{Shiha2026,
  author = {Shiha, Mohamed G and Keszthelyi, Daniel},
  title = {Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {3},
  pages = {420--421},
  doi = {10.1111/apt.70792}
}
Start for free →